Neurocrine Biosciences, Inc.
US ˙ NasdaqGS ˙ US64125C1099

SecurityNBIX / Neurocrine Biosciences, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership57,968 shares
Latest Disclosed Value $ 7,636,704
Citadel Advisors Llc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 57,968 shares of Neurocrine Biosciences, Inc. (US:NBIX) valued at $7,636,704 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 79,711 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -27.28% during the quarter. The current value of the position is $9,571,096 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 13,800 of underlying shares valued at $1,818,012 USD and put options representing 16,400 of underlying shares valued at $2,160,536 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,968 -21,743 -27.28 7,637 -32.45 0.0011
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 79,711 -713,528 -89.95 11,305 -89.85 0.0017
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 793,239 -1,255,836 -61.29 111,355 -56.76 0.0169
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,049,075 1,160,047 130.48 257,548 161.93 0.0447
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 889,028 -1,649,081 -64.97 98,326 -71.62 0.0186
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,538,109 773,519 43.84 346,452 70.40 0.0600
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,764,590 1,023,651 138.16 203,316 99.32 0.0392
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 740,939 -100,379 -11.93 102,005 -12.09 0.0206
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 841,318 729,318 651.18 116,035 686.30 0.0224
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 112,000 -624,207 -84.79 14,757 -82.18 0.0029
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 736,207 -570,066 -43.64 82,823 -32.76 0.0178
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,306,273 831,881 175.36 123,182 156.54 0.0255
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 474,392 288,824 155.64 48,018 116.64 0.0106
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 185,568 -50,078 -21.25 22,164 -11.44 0.0052
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 235,646 235,646 25,028 0.0057
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -93,098 -100.00 0 -100.00
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 93,098 -729,731 -88.69 8,728 -87.55 0.0018
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 822,829 -21,172 -2.51 70,080 -13.43 0.0143
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 844,001 176,015 26.35 80,948 24.52 0.0168
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 667,986 -467,361 -41.16 65,008 -41.12 0.0146
2021-05-21 2021-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,135,347 -12,160 -1.06 110,413 0.39 0.0271
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,135,347 -12,160 110,413 0.0271
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,147,507 836,009 268.38 109,988 267.20 0.0286
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 311,498 167,143 115.79 29,953 70.08 0.0085
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 144,355 -852,854 -85.52 17,611 -79.60 0.0063
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 997,209 573,054 135.10 86,308 89.31 0.0388
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 424,155 243,978 135.41 45,592 180.81 0.0198
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 180,177 124,617 224.29 16,236 246.11 0.0077
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 55,560 4,770 9.39 4,691 4.83 0.0022
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 50,790 50,790 4,475 0.0022
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 0 -439,598 -100.00 0 -100.00
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 439,598 23,431 5.63 54,048 32.20 0.0242
2018-08-14 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 416,167 97,981 30.79 40,884 54.94 0.0202
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 416,167 97,981 40,884
2018-05-14 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 318,186 -219,221 -40.79 26,387 -36.72 0.0145
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 318,186 -219,221 26,387
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 537,407 320,800 148.10 41,698 214.13 0.0254
2017-11-09 2017-09-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 216,607 200,055 1,208.65 13,274 1,644.28 0.0102
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 16,552 -961,980 -98.31 761 -98.20 0.0006
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 978,532 717,664 275.11 42,371 319.68 0.0387
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES Cmn 64125C109 260,868 -776,651 -74.86 10,096 -80.78 0.0102
2017-01-31 2016-09-30 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 1,037,519 103,974 11.14 52,540 23.83 0.0528
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 1,037,519 52,540
2017-01-31 2016-06-30 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 933,545 -878,118 -48.47 42,430 -40.78 0.0473
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 933,545 42,430
2017-01-31 2016-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 1,811,663 676,839 59.64 71,651 11.61 0.0904
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 1,811,663 71,651
2017-01-31 2015-12-31 13F/A-1 NEUROCRINE BIOSCIENCES Cmn 64125C109 1,134,824 656,626 137.31 64,197 237.38 0.0701
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 1,134,824 64,197
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 478,198 -334,286 -41.14 19,028 -50.96 0.0183
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 812,484 419,934 106.98 38,804 148.94 0.0340
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 392,550 -725,676 -64.90 15,588 -37.60 0.0174
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 1,118,226 182,918 19.56 24,981 70.45 0.0302
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 935,308 667,174 248.82 14,656 268.33 0.0184
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 268,134 224,291 511.58 3,979 463.60 0.0054
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 43,843 3,855 9.64 706 88.77 0.0010
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 39,988 37,106 1,287.51 374 1,033.33 0.0005
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 2,882 -13,471 -82.38 33 -84.93 0.0001
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn 64125C109 16,353 16,353 219 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 13,800 -13.75 1,818 -19.88 n/a n/a n/a
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 16,000 -39.16 2,269 -38.53 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 26,300 28.29 3,692 43.28 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 20,500 5.13 2,577 19.48 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 19,500 -63.14 2,157 -70.14 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 52,900 12.55 7,221 33.33 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 47,000 29.48 5,415 8.37 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 36,300 -6.92 4,997 -7.08 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 39,000 -1.27 5,379 3.34 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 39,500 -41.65 5,205 -31.67 n/a n/a n/a
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Call 67,700 141.79 7,616 188.48 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Call 28,000 12.45 2,640 4.76 n/a n/a n/a
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 24,900 -47.69 2,520 -55.67 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 47,600 59.73 5,685 79.62 n/a n/a n/a
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Call 29,800 -58.61 3,165 -54.91 n/a n/a n/a
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Call 72,000 34.33 7,019 39.68 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 53,600 38.14 5,025 52.04 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 38,800 55.82 3,305 38.40 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES Cmn Call 24,900 -62.72 2,388 -63.27 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 66,800 10.96 6,501 11.05 n/a n/a n/a
2021-05-21 2021-03-31 13F/A NEUROCRINE BIOSCIENCES COM Call 60,200 30.87 5,854 32.77 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 60,200 5,854 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 46,000 -22.30 4,409 -22.55 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 59,200 -49.23 5,693 -59.98 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES Cmn Call 116,600 8.36 14,225 52.74 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES Cmn Call 107,600 -63.09 9,313 -70.28 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES Cmn Call 291,500 281.54 31,333 355.16 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES Cmn Call 76,400 -9.48 6,884 -3.40 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES Cmn Call 84,400 -21.63 7,126 -24.89 n/a n/a n/a
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES Cmn Call 107,700 -54.52 9,488 -43.89 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES Cmn Call 236,800 128.79 16,910 32.89 n/a n/a n/a
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES Cmn Call 103,500 76.62 12,725 121.04 n/a n/a n/a
2018-08-14 2018-06-30 13F/A NEUROCRINE BIOSCIENCES Cmn Call 58,600 27.95 5,757 51.58 n/a n/a n/a
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES Cmn Call 58,600 5,757 n/a n/a n/a
2018-05-14 2018-03-31 13F/A NEUROCRINE BIOSCIENCES Cmn Call 45,800 229.50 3,798 251.99 n/a n/a n/a
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES Cmn Call 45,800 3,798 n/a n/a n/a
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES Cmn Call 13,900 -9.15 1,079 15.03 n/a n/a n/a
2017-11-09 2017-09-30 13F NEUROCRINE BIOSCIENCES Cmn Call 15,300 -11.56 938 17.84 n/a n/a n/a
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES Cmn Call 17,300 -50.14 796 -47.04 n/a n/a n/a
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES Cmn Call 34,700 65.24 1,503 84.87 n/a n/a n/a
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES Cmn Call 21,000 40.00 813 6.97 n/a n/a n/a
2017-01-31 2016-09-30 13F/A NEUROCRINE BIOSCIENCES Cmn Call 15,000 -63.05 760 -58.81 n/a n/a n/a
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 15,000 760 n/a n/a n/a
2017-01-31 2016-06-30 13F/A NEUROCRINE BIOSCIENCES Cmn Call 40,600 -31.65 1,845 -21.46 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 40,600 1,845 n/a n/a n/a
2017-01-31 2016-03-31 13F/A NEUROCRINE BIOSCIENCES Cmn Call 59,400 5.32 2,349 -26.39 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 59,400 2,349 n/a n/a n/a
2017-01-31 2015-12-31 13F/A NEUROCRINE BIOSCIENCES Cmn Call 56,400 -25.79 3,191 5.52 n/a n/a n/a
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 56,400 3,191 n/a n/a n/a
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 76,000 2.01 3,024 -15.01 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 74,500 21.53 3,558 46.18 n/a n/a n/a
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 61,300 -24.51 2,434 34.18 n/a n/a n/a
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 81,200 35.11 1,814 92.57 n/a n/a n/a
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 60,100 114.64 942 126.44 n/a n/a n/a
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 28,000 8.95 416 0.48 n/a n/a n/a
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 25,700 42.78 414 146.43 n/a n/a n/a
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 18,000 -63.41 168 -69.84 n/a n/a n/a
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 49,200 151.02 557 112.60 n/a n/a n/a
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Call 19,600 262 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 16,400 -20.00 2,161 -25.70 n/a n/a n/a
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 20,500 64.00 2,908 65.74 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 12,500 -29.38 1,755 -21.13 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 17,700 -37.46 2,225 -28.92 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 28,300 9.69 3,130 -11.13 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 25,800 -45.68 3,522 -35.65 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 47,500 69.04 5,473 41.47 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 28,100 97.89 3,869 97.55 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 14,200 39.22 1,958 45.79 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 10,200 -67.20 1,344 -61.61 n/a n/a n/a
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 31,100 5.78 3,499 26.19 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Put 29,400 203.09 2,772 182.57 n/a n/a n/a
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Put 9,700 90.20 982 61.08 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Put 5,100 2.00 609 14.69 n/a n/a n/a
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 5,000 -39.76 531 -34.36 n/a n/a n/a
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Put 8,300 -89.82 809 -89.41 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 81,500 120.87 7,641 143.11 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 36,900 -5.63 3,143 -16.19 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES Cmn Put 39,100 -11.74 3,750 -13.01 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 44,300 53.29 4,311 53.36 n/a n/a n/a
2021-05-21 2021-03-31 13F/A NEUROCRINE BIOSCIENCES COM Put 28,900 -7.07 2,811 -5.70 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 28,900 2,811 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 31,100 -31.65 2,981 -31.86 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 45,500 -13.99 4,375 -32.21 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES Cmn Put 52,900 -0.94 6,454 39.64 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES Cmn Put 53,400 -39.39 4,622 -51.19 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES Cmn Put 88,100 61.65 9,470 92.83 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES Cmn Put 54,500 -10.07 4,911 -4.01 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES Cmn Put 60,600 -15.95 5,116 -19.46 n/a n/a n/a
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES Cmn Put 72,100 29.21 6,352 59.40 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES Cmn Put 55,800 35.77 3,985 -21.14 n/a n/a n/a
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES Cmn Put 41,100 -17.14 5,053 3.69 n/a n/a n/a
2018-08-14 2018-06-30 13F/A NEUROCRINE BIOSCIENCES Cmn Put 49,600 115.65 4,873 155.53 n/a n/a n/a
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES Cmn Put 49,600 4,873 n/a n/a n/a
2018-05-14 2018-03-31 13F/A NEUROCRINE BIOSCIENCES Cmn Put 23,000 -0.86 1,907 5.94 n/a n/a n/a
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES Cmn Put 23,000 1,907 n/a n/a n/a
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES Cmn Put 23,200 -4.92 1,800 20.40 n/a n/a n/a
2017-11-09 2017-09-30 13F NEUROCRINE BIOSCIENCES Cmn Put 24,400 -53.79 1,495 -38.45 n/a n/a n/a
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES Cmn Put 52,800 36.79 2,429 45.36 n/a n/a n/a
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES Cmn Put 38,600 -34.91 1,671 -27.19 n/a n/a n/a
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES Cmn Put 59,300 146.06 2,295 88.11 n/a n/a n/a
2017-01-31 2016-09-30 13F/A NEUROCRINE BIOSCIENCES Cmn Put 24,100 -22.51 1,220 -13.66 n/a n/a n/a
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 24,100 1,220 n/a n/a n/a
2017-01-31 2016-06-30 13F/A NEUROCRINE BIOSCIENCES Cmn Put 31,100 -47.38 1,413 -39.54 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 31,100 1,413 n/a n/a n/a
2017-01-31 2016-03-31 13F/A NEUROCRINE BIOSCIENCES Cmn Put 59,100 -31.68 2,337 -52.24 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 59,100 2,337 n/a n/a n/a
2017-01-31 2015-12-31 13F/A NEUROCRINE BIOSCIENCES Cmn Put 86,500 16.73 4,893 65.98 n/a n/a n/a
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 86,500 4,893 n/a n/a n/a
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 74,100 103.01 2,948 69.13 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 36,500 -2.93 1,743 16.74 n/a n/a n/a
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 37,600 -4.33 1,493 70.05 n/a n/a n/a
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 39,300 54.12 878 119.50 n/a n/a n/a
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 25,500 40.11 400 48.15 n/a n/a n/a
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 18,200 32.85 270 22.17 n/a n/a n/a
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 13,700 -17.96 221 41.67 n/a n/a n/a
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 16,700 -20.10 156 -34.18 n/a n/a n/a
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 20,900 -26.92 237 -38.12 n/a n/a n/a
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES INC CMN STOCK Cmn Put 28,600 383 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.